Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries

Overview

Journal Clin Pathol

Publisher Sage Publications

Date 2024 May 15

PMID 38746645

Authors

Proma Rani Das

Sakif Ahamed Khan

Mohammad Safiqul Islam

Syed Masudur Rahman Dewan

Affiliations

Soon will be listed here.

References

Lucero-Prisno 3rd D, Ogunkola I, Esu E, Adebisi Y, Lin X, Li H . Can Africa achieve herd immunity?. Glob Health Res Policy. 2021; 6(1):46. PMC: 8636285. DOI: 10.1186/s41256-021-00231-1. View

Das P, Khan S, Rahman J, Dewan S . Effective Preventative Measures are Essential to Lower Disease Burden From Dengue and COVID-19 Co-infection in Bangladesh. Environ Health Insights. 2023; 17:11786302231212774. PMC: 10685758. DOI: 10.1177/11786302231212774. View

Khan S, Bhuiyan M, Dewan S . JN.1: The Present Public Health Concern Pertains to the Emergence of a Novel Variant of COVID-19. Environ Health Insights. 2024; 18:11786302241228958. PMC: 10832400. DOI: 10.1177/11786302241228958. View

Dewan S, Islam M . Increasing reinfections and decreasing effectiveness of COVID-19 vaccines urge the need for vaccine customization. Ann Med Surg (Lond). 2022; 84:104961. PMC: 9671613. DOI: 10.1016/j.amsu.2022.104961. View

Roknuzzaman A, Sarker R, Nazmunnahar , Shahriar M, Mosharrafa R, Islam M . The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts. Clin Pathol. 2024; 17:2632010X241228053. PMC: 10804921. DOI: 10.1177/2632010X241228053. View

Schernhammer E, Weitzer J, Laubichler M, Birmann B, Bertau M, Zenk L . Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government. J Public Health (Oxf). 2021; 44(1):e106-e116. PMC: 8135852. DOI: 10.1093/pubmed/fdab122. View

Guzman J, Hafner T, Maiga L, Giedion U . COVID-19 vaccines pricing policy options for low-income and middle- income countries. BMJ Glob Health. 2021; 6(3). PMC: 7969756. DOI: 10.1136/bmjgh-2021-005347. View

Chatterjee P, Nair P, Chersich M, Terefe Y, Singh Chauhan A, Quesada F . One Health, "Disease X" & the challenge of "Unknown" Unknowns. Indian J Med Res. 2021; 153(3):264-271. PMC: 8204831. DOI: 10.4103/ijmr.IJMR_601_21. View

Patwary M, Haque M, Bardhan M, Rodriguez-Morales A . COVID-19 and Dengue Co-epidemic During the Second Wave of the Pandemic in Bangladesh: A Double Blow for an Overburdened Health-Care System. Disaster Med Public Health Prep. 2022; :1-3. PMC: 9253440. DOI: 10.1017/dmp.2022.105. View

10.

Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M . COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021; 27(8):1385-1394. PMC: 8363502. DOI: 10.1038/s41591-021-01454-y. View

11.

Corpuz J . Multisectoral Approach on COVID-19 vaccination: a proposed solution on vaccine hesitancy. J Public Health (Oxf). 2021; 43(2):e370-e371. PMC: 7989299. DOI: 10.1093/pubmed/fdab085. View

12.

Lucero-Prisno 3rd D, Shomuyiwa D, Vicente C, Mendez M, Qaderi S, Lopez J . Achieving herd immunity in South America. Glob Health Res Policy. 2023; 8(1):2. PMC: 9891655. DOI: 10.1186/s41256-023-00286-2. View

13.

Marlia A, Nafiz C, Dewan I, Dewan S . Present Public Health Concern: Could the Transmission of the JN.1 Variant of COVID-19 Place Bangladesh at Risk of Transmitting the Disease?. Environ Health Insights. 2024; 18:11786302241238967. PMC: 10929023. DOI: 10.1177/11786302241238967. View

14.

Crawshaw A, Deal A, Rustage K, Forster A, Campos-Matos I, Vandrevala T . What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?. J Travel Med. 2021; 28(4). PMC: 8083646. DOI: 10.1093/jtm/taab048. View

15.

Feemster K . Building vaccine acceptance through communication and advocacy. Hum Vaccin Immunother. 2020; 16(5):1004-1006. PMC: 7227644. DOI: 10.1080/21645515.2020.1746603. View

16.

Alakija A . Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threats. Lancet Infect Dis. 2023; 23(8):e310-e317. DOI: 10.1016/S1473-3099(23)00279-7. View

17.

Jiang S, Shi Z . The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus. Virol Sin. 2020; 35(3):263-265. PMC: 7091198. DOI: 10.1007/s12250-020-00206-5. View

18.

Dhama K, Sharun K, Tiwari R, Dhawan M, Emran T, Rabaan A . COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021; 17(10):3495-3499. PMC: 8437517. DOI: 10.1080/21645515.2021.1926183. View

19.

Simpson S, Kaufmann M, Glozman V, Chakrabarti A . Disease X: accelerating the development of medical countermeasures for the next pandemic. Lancet Infect Dis. 2020; 20(5):e108-e115. PMC: 7158580. DOI: 10.1016/S1473-3099(20)30123-7. View